TG Therapeutics, Inc. TGTX

Set alert

Price alert · TGTX

All alert types
61.03 USD +1.08 +1.80%

As of Nov 3, 2:54 PM ET

Bid
60.98 × 1
Ask
61.06 × 2
60.02 Day range 62.20
26.76 52-week range 63.60
YTD
+104.73%
1 year
+81.15%
Open
60.02
Prev close
59.95
Mkt cap
9.34B
Vol
852.91K
Avg vol
1.81M
EPS
2.75
P/E
22.20
Div yield
0.00%
More statistics
Low
60.02
High
62.20
Forward P/E
22.14
Beta
1.81
Short ratio
16.22
Inst. own
74.69%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
55.33
200-d avg
43.81
1y target
69.71

5D chart

Chart tools
Interval

Signals (130)
NameTimeAgo
MACD: Sell SignalNov 3, 11:00 AM3 hours ago
SMA: BullishNov 3, 10:35 AM4 hours ago
SMA: BearishNov 3, 10:25 AM4 hours ago
SMA: BullishNov 3, 10:20 AM4 hours ago
SMA: BearishNov 3, 10:10 AM4 hours ago
MACD: Buy SignalNov 3, 9:35 AM5 hours ago
SMA: BullishNov 3, 9:30 AM5 hours ago
SMA: BullishNov 3, 9:30 AM5 hours ago
MACD: Sell SignalNov 2, 3:35 PM23 hours ago
SMA: BearishNov 2, 3:30 PM23 hours ago
SMA: BearishNov 2, 3:30 PM23 hours ago
SMA: BullishNov 2, 2:50 PM1 day ago
SMA: BearishNov 2, 2:45 PM1 day ago
SMA: BullishNov 2, 2:40 PM1 day ago
SMA: BullishNov 2, 2:25 PM1 day ago
MACD: Buy SignalNov 2, 2:25 PM1 day ago
SMA: BearishNov 2, 2:20 PM1 day ago
MACD: Sell SignalNov 2, 2:20 PM1 day ago
MACD: Buy SignalNov 2, 2:15 PM1 day ago
SMA: BullishNov 2, 2:10 PM1 day ago

Newest 20 of 130.

Revenue & Expenses

Revenue by
Income Tax Benefit → Gross Profit & Other Income: $339.79MGross Profit & Other Income → Net Income: $447.18MGross Profit & Other Income → Selling, General & Admin: $232.03MGross Profit & Other Income → Research & Development: $160.22MGross Profit & Other Income → Other Expenses: $15.93MProduct → Revenue: $606.93MGross Profit → Gross Profit & Other Income: $515.57MRevenue → Gross Profit: $515.57MRevenue → Cost of Revenue: $100.71MRoyalty → Revenue: $5.62MOther Revenue → Revenue: $3.59MLicense Revenue → Revenue: $152.00KIncome Tax Benefit$339.79MGross Profit$515.57MCost of Revenue$100.71MGross Profit & Other Income$855.36MNet Income$447.18MSelling, General & Admin$232.03MResearch & Development$160.22MOther Expenses$15.93MRevenue$616.29MProduct$606.93MRoyalty$5.62MOther Revenue$3.59MLicense Revenue$152.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

TGTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
616.29M329.00M233.66M2.79M6.69M
515.57M290.52M219.53M2.52M5.90M
123.32M41.93M20.63M-218.32M-344.77M
447.18M23.38M12.67M-223.81M-348.10M
2.770.150.09-1.65-2.63
TGTX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
80.49M181.19M94.22M103.58M300.15M
1.06B577.69M329.59M193.57M379.63M
415.23M355.33M169.09M134.99M142.48M
252.67M252.56M109.35M81.48M77.61M
648.02M222.36M160.50M58.59M237.15M
TGTX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-24.77M-40.52M-31.41M-176.17M-295.63M
13.80M-1.04M-50.65M-20.01M-332.00K
-89.73M128.53M72.70M-391.00K41.42M
-214.00K-45.00K0-14.00K-401.00K
-100.70M86.97M-9.36M-196.57M-254.55M